Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 11, 2000, Pages 624-630

  Schuller, H M ^a   Porter, B ^a   Riechert, A ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Beta adrenergic modulation; Lung adenocarcinoma; NNK

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NITROSAMINE; PROPRANOLOL;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; HAMSTER; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; SMOKING;

EID: 0033784638     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008474     Document Type: Article

References (51)

1. Beta-adrenergic receptors and their regulation
2. The relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines
3. 6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
4. Endotoxin-induced alteration in the expression of leptin and the β3-adrenergic receptor in adipose tissue
5. Role of arachidonic acid metabolites in the action of a β-adrenergic agonist on human monocytes
6. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
7. Inhibition of lung tumourigenesis by sulindac: Comparison of two experimental protocols
8. Metabolism of tobacco-specific N-nitrosamines by cultured human tissues
9. Comparative carcinogenicity in A/J mice and metabolisms by cultured mouse peripheral lung of N-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and their analogues
10. How to prevent the progression of chronic bronchitis: The role of smoking cessation prevention
11. Lung cancer in nonsmoking women: A multicenter case-control study
12. Specificity of expression and effects of eicosanoids mediators in normal physiology and man disease
13. Pathophysiologic basis for adjunctive therapies in the treatment and secondary prevention of myocardial infarction
14. Recent studies on the mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen
15. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke
16. Catecholamines and sympathomimetic drugs
17. Adrenergic receptor antagonists
18. Cigarette smoking and adenocarcinoma of the lung: The relevance of nicotine-derived N-nitrosamines
19. The changing cigarette
20. Receptor binding studies
21. Effects of tobacco smoking on various histological types of lung cancer
22. Overview of the biology of lung cancer
23. Effects of genetic polymorphism in ex vivo and in vivo function of β2-adrenoreceptors in asthmatic patients
24. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California
25. 2 adrenergic receptor-Src protein kinase complexes
26. Studies on the regulation of secretion in Clara cells with evidence for chemical nonautonomic mediation of the secretory response to increased ventilation in rat lungs
27. Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC
28. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta
29. β-Adrenergic receptors in the lungs: An introduction
30. A survey of smoking and quitting patterns among black Americans
31. Lung cancer in women: The importance of smoking, family history, and medical history of respiratory disease
32. β-Adrenergic signal transduction in peripheral lung adenocarcinoma: Implications for individuals with preexisting chronic lung disease
33. Cancer statistics 1997
34. Evidence for β2-adrenergic/arachidonic acid pathway in ventricular cardiomyocytes. Regulation by the β1-adrenergic/cAMP pathway
35. Drugs used in the treatment of asthma
36. Mutational activation of the K-ras oncogene: A possible pathogenetic factor in adenocarcinoma of the lung
37. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung
38. Inhibitors of lipoxygenase: A new class of cancer chemopreventive agents
39. Beta-adrenergic receptor stimulated prostacyclin synthesis in rabbit coronary epithelial cells is mediated by selective activation of phospholipase D: Inhibition by adenosine 3'5'-cyclic monophosphate
40. α- and β-Adrenoreceptors: From the gene to the clinic. 2. Structure-activity relationships and therapeutic applications
41. The impact of air pollution on allergic disease
42. Augmented myocardial ischemia by nicotine - Mechanisms and their possible significance
43. Pathobiology of NNK-induced lung tumors in hamsters and the modulating effect of hyperoxia
44. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a β-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via β-adrenergic receptor-mediated release of arachidonic acid
45. 1-adrenoreceptors: Sequence corrections and direct comparisons with other species homologues
46. Prostanoid biosynthesis and mechanisms of action
47. Mitogen-activated protein kinase cascades and regulation of gene expression
48. COPD and lung cancer
49. K-ras oncogene activation in adenocarcinomas from former smokers. Evidence that K-ras mutations are early an early and irreversible event in the development of adenocarcinoma of the lung
50. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type gentotype of the NAD(P)H: Quinone oxidoreductase polymorphism
51. Smoking and lung cancer: Scientific challenges and opportunities